IL17A and neoplasm: Although some researchers are cautious about the dual role of Th17/IL-17A signaling in tumor progression11, numerous studies have demonstrated that IL-17A can enhance angiogenesis, proliferation, metastasis or drug resistance in multiple cancers, which supports the potential value of blocking IL-17A as an antitumor therapy15.